Investigating a new target for controlling oil production in skin glands
MPZL3 as a Therapeutically Targetable Mitochondrial Regulator of Sebaceous Gland Homeostasis and Sebum Production
This study is looking at how a protein called MPZL3 affects the oil-producing glands in your skin, which could help find new ways to treat skin issues like acne and hair loss.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Miami School of Medicine NIH-funded |
| Lab location | 1 site (Coral Gables, United States) |
| Project ID | NIH-11042257 on NIH RePORTER |
What this research studies
This research focuses on understanding how a protein called MPZL3 regulates the sebaceous glands, which are responsible for producing sebum, an oil that helps maintain skin health. By studying both mouse models and human skin, the researchers aim to uncover the molecular mechanisms behind sebocyte proliferation and sebum production. The goal is to identify new therapeutic targets for skin conditions like acne and alopecia, which are linked to abnormal sebum production. This could lead to innovative treatments that improve skin health and manage related diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals suffering from acne vulgaris, scarring alopecia, or other skin conditions related to sebaceous gland dysfunction.
Not a fit: Patients with skin conditions unrelated to sebaceous gland function may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for skin conditions such as acne and alopecia by targeting the regulation of sebum production.
How similar studies have performed: Previous research has shown promise in targeting molecular regulators of skin conditions, suggesting that this approach could yield significant advancements.
Where this research is happening
Coral Gables, United States
- University of Miami School of Medicine — Coral Gables, United States (Active)
Researchers
- Principal investigator: Wikramanayake, Tongyu Cao — University of Miami School of Medicine
- Study coordinator: Wikramanayake, Tongyu Cao
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.